Open AccessEvaluation of Treatment Efficacy of Tyrosine Kinase Inhibitors in Rare Single EGFR Exon 21 L861Q Mutation: Single Center Experience
Author(s) -
Pınar Gürsoy,
Burcu Çakar,
Sercan On,
Erdem Göker,
Denız Nart
Publication year - 2022
Language(s) - English
DOI - 10.5152/turkthoracj.2022.21270
Subject(s) - afatinib , erlotinib , epidermal growth factor receptor , medicine , lung cancer , oncology , tyrosine kinase inhibitor , erlotinib hydrochloride , tyrosine kinase , epidermal growth factor , cancer research , cancer , receptor